Coya Therapeutics, Inc. (NASDAQ: COYA) ("Coya" or the "Company"), a clinical-stage biotechnology company focused on ...
GH Research (GHRS) stock jumped 20% after-hours ahead of its Jan 5 update on Phase 3 depression program and FDA IND status on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback